欧洲脑癌诊断市场预测至 2028 年 - COVID-19 影响和按诊断类型（成像测试、腰椎穿刺、活检、分子测试等）进行的区域分析；癌症类型（听神经瘤、星形细胞瘤、颅咽管瘤、神经节神经瘤、多形性胶质母细胞瘤、脑膜瘤、室管膜瘤等）；最终用户（医院、专科诊所、门诊手术中心等）
No. of Pages: 161 | Report Code: TIPRE00025898 | Category: Life Sciences
No. of Pages: 161 | Report Code: TIPRE00025898 | Category: Life Sciences
脑癌是由于大脑中导致肿瘤的细胞在细胞外生长而引起的。肿瘤包括原发性脑肿瘤和继发性脑肿瘤。原发性脑肿瘤在大脑中形成，不会扩散到身体其他部位，而继发性肿瘤，也称为转移瘤，是那些始于身体其他部位的癌症。脑肿瘤分为40种主要类型，进一步分为两大类，包括良性（即生长缓慢且不易扩散）和恶性（即癌变且更容易扩散）。
< p>因此，脑癌患病率的增加预计将在未来几年对脑癌诊断产生巨大需求，预计这将进一步推动脑癌诊断市场的发展。癌症患者已经在 COVID-19 大流行期间受到了负面影响，因为其中许多人可能受到免疫抑制并且年龄较大。此外，世界各地许多诊所的癌症随访或影像预约都被推迟。推迟常规筛查将导致新癌症诊断的延迟。诊所正在继续根据当地 COVID-19 疫情监测和调整预约时间表。关于癌症患者的 COVID-19 的研究有限，但一致表明该人群面临更严重的 COVID-19 疾病的风险。最近研究的数据还表明，与成人相比，儿科癌症患者患严重 COVID-19 疾病的风险较低。通过肺部、大脑和胃肠道成像检测到的 SARS-CoV-2 感染的某些特征可能会令放射科医生的诊断感到困惑。解释癌症诊断、分期和治疗反应。最后，随着诊所开始重新开放进行常规预约，我们已经制定了相关方案，以减少患者在就诊期间接触 SARS-CoV-2。本综述详细介绍了关于 COVID-19 大流行对癌症患者和癌症成像影响的不同观点。
欧洲脑癌诊断市场预计将从 2021 年的 2.075 亿美元增长到 601.0 美元到 2028 年将达到 100 万；预计 2021 年至 2028 年复合年增长率为 16.4%。人工智能涉及使用功能强大的计算机来执行通常与人类智能相关的任务。一种称为深度学习的人工智能使用复杂的数学算法（有时称为卷积神经网络）从数据中提取特征，然后“训练”它们。这种训练使算法能够识别模式并执行分析图像等任务。为了将SRH成像仪的强大功能与AI结合起来，研究人员开始对SRH产生的脑肿瘤组织图像进行算法训练。研究人员指出，人工智能技术和病理学家相互验证的能力凸显了病理学家需要与人工智能技术合作来解释具有挑战性的病例并确保尽可能高的诊断准确性。 SRH 和人工智能成像都是新兴技术，因此将它们整合到医疗保健中将具有挑战性。人工智能技术使外科医生能够快速准确地识别含有肿瘤或健康组织的区域。因此，SRH 人工智能越来越多地用于增强手术期间的脑肿瘤诊断。
就诊断类型而言，影像测试细分市场在2020年欧洲脑癌诊断市场中占据最大份额。就癌症类型而言，多形性胶质母细胞瘤细分市场在2020年欧洲脑癌诊断市场中占据最大份额。在最终用户方面， 2020年，医院细分市场在欧洲脑癌诊断市场中占据最大份额。
主要来源和上市公司
在准备欧洲脑癌诊断市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括 Thermo Fisher Scientific Inc.、Siemens Healthineers A、GE Healthcare、Biocept, Inc.、Koninklijke Philips NV、Canon Medical Systems、Hitachi, Ltd. 和 Neusoft Medical Systems。
按诊断类型
按癌症类型
由最终用户
按国家/地区
< strong>提及的公司
Strategic insights for Europe Brain Cancer Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 207.5 Million |
| Market Size by 2028 | US$ 601.0 Million |
| Global CAGR (2021 - 2028) | 16.4% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 诊断类型
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Brain Cancer Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Brain Cancer Diagnostics Market is valued at US$ 207.5 Million in 2021, it is projected to reach US$ 601.0 Million by 2028.
As per our report Europe Brain Cancer Diagnostics Market, the market size is valued at US$ 207.5 Million in 2021, projecting it to reach US$ 601.0 Million by 2028. This translates to a CAGR of approximately 16.4% during the forecast period.
The Europe Brain Cancer Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Brain Cancer Diagnostics Market report:
The Europe Brain Cancer Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Brain Cancer Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Brain Cancer Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Brain Cancer Diagnostics Market
